These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23163396)

  • 1. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
    Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
    Crijns I; Straus S; Luteijn M; Gispen-de Wied C; Raine J; de Jong-van den Berg L
    Drug Saf; 2012 Jan; 35(1):27-32. PubMed ID: 22050373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
    Lagan BM; Dolk H; White B; Uges DR; Sinclair M
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):411-8. PubMed ID: 24493556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.
    Crijns HJ; Straus SM; Gispen-de Wied C; de Jong-van den Berg LT
    Br J Dermatol; 2011 Feb; 164(2):238-44. PubMed ID: 20716214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
    Crijns HJ; van Rein N; Gispen-de Wied CC; Straus SM; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1060-6. PubMed ID: 22228673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' attitudes toward and practices with adolescents.
    Conard LA; Fortenberry JD; Blythe MJ; Orr DP
    Arch Pediatr Adolesc Med; 2003 Apr; 157(4):361-5. PubMed ID: 12695232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
    Mitchell AA; Van Bennekom CM; Louik C
    N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
    Boucher N; Beaulac-Baillargeon L
    Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologists' attitudes, prescription, and counseling patterns for isotretinoin: a questionnaire-based study.
    Nagler AR; Orlow SJ
    J Drugs Dermatol; 2015 Feb; 14(2):184-9. PubMed ID: 25689814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who's heard of the Pregnancy Prevention Program?
    Hatcher L
    Can Fam Physician; 1999 Apr; 45():871-2. PubMed ID: 10216779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of pregnant women using isotretinoin.
    Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pox on your practice. iPLEDGE program scars dermatologists.
    Ortolon K
    Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
    [No Abstract]   [Full Text] [Related]  

  • 19. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
    Atanackovic G; Koren G
    Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' knowledge of isotretinoin safety.
    Alrwisan AA; Alshammari TM; Tahir KW; Aleissa FM; Aljadhey HS
    Saudi Med J; 2014 Jan; 35(1):81-4. PubMed ID: 24445895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.